# Food-effect on PK and PD of Single Oral Dose of HIP1601 in Healthy Subjects

> **NCT04204629** · PHASE1 · COMPLETED · sponsor: **Hanmi Pharmaceutical Company Limited** · enrollment: 25 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** HIP1601 40mg

## Key facts

- **NCT ID:** NCT04204629
- **Lead sponsor:** Hanmi Pharmaceutical Company Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-13
- **Primary completion:** 2020-02-20
- **Final completion:** 2020-02-20
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2022-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04204629

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04204629, "Food-effect on PK and PD of Single Oral Dose of HIP1601 in Healthy Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04204629. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*